U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H4NO3S.H4N
Molecular Weight 200.2164
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMMONIUM SACCHARIN

SMILES

c1ccc2c(c1)C(=NS2(=O)=O)O.N

InChI

InChIKey=XTPLQANXHDDXIH-UHFFFAOYSA-N
InChI=1S/C7H5NO3S.H3N/c9-7-5-3-1-2-4-6(5)12(10,11)8-7;/h1-4H,(H,8,9);1H3

HIDE SMILES / InChI

Molecular Formula H3N
Molecular Weight 17.0305
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C7H5NO3S
Molecular Weight 183.1859
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment:: description was created based on several sources, including http://www.diabetes.co.uk/sweeteners/saccharin.html http://www.ukfoodguide.net/e954.htm

Saccharin is the most established of the artificial sweeteners on the market, this mixture of dextrose and saccharin has been in use for over a century and is found in diet versions of soft drinks. It is 300-500 times sweeter than sugar and contains zero calories. In 1977, the FDA tried to ban its use after evidence showed it caused cancer in rats. Extensive lobbying by the diet food industry allowed products to stay on the shelves as long as they carried warnings about the cancer risks in animals. This warning was removed in 2001 when the Calorie Control Council insisted the link between animal and human cancers could not automatically be made. Consumption of saccharin-sweetened products can benefit diabetics as the substance goes directly through the human digestive system without being digested. While saccharin has no food energy, it can trigger the release of insulin in humans due to its sweet taste. The T1R2/R3 sweet taste receptor exist on the surface of pancreatic beta cells. Saccharin is a unique in that it inhibits glucose-stimulated insulin secretion (GSIS) at submaximal and maximal glucose concentrations, with the other sweeteners having no effect. Investigation of saccharin’s dose-response characteristics showed that concentrations of 0.1 and 0.5 mM stimulated insulin secretion, while concentrations of 1 and 2.5 mM inhibited insulin secretion. Saccharin’s effect on insulin secretion was shown to be reversible in INS-1 832/13 clonal pancreatic beta cells after chronic exposure to 1 mM saccharin. Artificial sweeteners may affect insulin secretion via interaction with the sweet taste receptor, also saccharin may affect other cellular processes linked to insulin secretion, and that these effects are both time- and concentration-dependent

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q8TE23
Gene ID: 80834.0
Gene Symbol: TAS1R2
Target Organism: Homo sapiens (Human)
Target ID: Q7RTX0
Gene ID: 83756.0
Gene Symbol: TAS1R3
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
14 μg/mL
2 g single, oral
dose: 2 g
route of administration: Oral
experiment type: SINGLE
co-administered:
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FED
27 μg/mL
2 g single, oral
dose: 2 g
route of administration: Oral
experiment type: SINGLE
co-administered:
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
5800 μg × min/mL
10 mg/kg single, intravenous
dose: 10 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered: PROBENECID
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
3700 μg × min/mL
10 mg/kg single, intravenous
dose: 10 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
6500 μg × min/mL
2 g single, oral
dose: 2 g
route of administration: Oral
experiment type: SINGLE
co-administered:
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FED
6800 μg × min/mL
2 g single, oral
dose: 2 g
route of administration: Oral
experiment type: SINGLE
co-administered:
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer



Drug as perpetrator​

Drug as perpetrator​

TargetModalityActivityMetaboliteClinical evidence
no
no (co-administration study)
Comment: coadministration with bupropion: had no effect on the CYP2B activity
no
no (co-administration study)
Comment: coadministration with bupropion: saccharin had no inhibitory effect on CYP2B activity in vivo
Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
no
PubMed

PubMed

TitleDatePubMed
Cytological and lectin histochemical characterization of secretion production and secretion composition in the tubular glands of the canine anal sacs.
2001
Demonstration of conformational changes associated with activation of the maltose transport complex.
2001 Apr 13
Serial changes in 14C-deoxyglucose and 201Tl uptake in autoimmune myocarditis in rats.
2001 Feb
Na+-to-sugar stoichiometry of SGLT3.
2001 Feb
Automated noninvasive measurement of cyclophosphamide-induced changes in murine voiding frequency and volume.
2001 Feb
Characterization of EDTA-soluble polysaccharides from the scape of Musa paradisiaca (banana).
2001 Feb
Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein.
2001 Feb
Conditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat.
2001 Feb
Dietary effects of ortho-phenylphenol and sodium ortho-phenylphenate on rat urothelium.
2001 Feb
Negative-ion electrospray mass spectrometry of neutral underivatized oligosaccharides.
2001 Feb 1
Cysteine residues in the D-galactose-H+ symport protein of Escherichia coli: effects of mutagenesis on transport, reaction with N-ethylmaleimide and antibiotic binding.
2001 Feb 1
Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity.
2001 Feb 15
Identification and characterization of neutral endopeptidase (EC 3. 4. 24. 11) from human prostasomes--localization in prostatic tissue and cell lines.
2001 Feb 15
Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope.
2001 Feb 15
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver.
2001 Feb 8
Diabetes. Dialogue between muscle and fat.
2001 Feb 8
Munc18c regulates insulin-stimulated glut4 translocation to the transverse tubules in skeletal muscle.
2001 Feb 9
A novel assay method for glycosphingolipid deacylase by enzyme-linked immunochemical detection of lysoglycosphingolipid.
2001 Jan
An overview of pathophysiology and treatment of insulin resistance.
2001 Jan
Distinct differences in binding capacity to saccharide epitopes in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas, and glioblastomas.
2001 Jan
What's the truth about the health risks of sugar substitutes such as saccharin and aspartame?
2001 Jan
High-resolution genetic mapping of the saccharin preference locus (Sac) and the putative sweet taste receptor (T1R1) gene (Gpr70) to mouse distal Chromosome 4.
2001 Jan
Placental glucose transport in gestational diabetes mellitus.
2001 Jan
Improved water solubility of neohesperidin dihydrochalcone in sweetener blends.
2001 Jan
Nasal mucociliary clearance in healthy children in a tropical country.
2001 Jan
Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes.
2001 Jan
The synaptic vesicle protein, cysteine-string protein, is associated with the plasma membrane in 3T3-L1 adipocytes and interacts with syntaxin 4.
2001 Jan
Functional asymmetry of the sodium-D-glucose cotransporter expressed in yeast secretory vesicles.
2001 Jan 15
Polysaccharides of green Arabica and Robusta coffee beans.
2001 Jan 15
The occurrence of internal (1 --> 5)-linked arabinofuranose and arabinopyranose residues in arabinogalactan side chains from soybean pectic substances.
2001 Jan 15
Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors.
2001 Jan 23
Engineering conformational flexibility in the lactose permease of Escherichia coli: use of glycine-scanning mutagenesis to rescue mutant Glu325-->Asp.
2001 Jan 23
Characteristics of endothelial cells derived from the blood-brain barrier and of astrocytes in culture.
2001 Jan 26
Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
2001 Jan 26
The crystal structure of a liganded trehalose/maltose-binding protein from the hyperthermophilic Archaeon Thermococcus litoralis at 1.85 A.
2001 Jan 26
Glycolipid antigen processing for presentation by CD1d molecules.
2001 Jan 26
Nitric oxide modulates lithium-induced conditioned taste aversion.
2001 Jan 29
Effect of growth hormone on intestinal Na+/glucose cotransporter activity.
2001 Jan-Feb
Development of cataractous macrophthalmia in mice expressing an active MEK1 in the lens.
2001 Mar
Time-resolved study of the inner space of lactose permease.
2001 Mar
Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract.
2001 Mar
Hormonal regulation of chicken intestinal NHE and SGLT-1 activities.
2001 Mar
Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter.
2001 Mar
Ceramide dissociates 3'-phosphoinositide production from pleckstrin homology domain translocation.
2001 Mar 1
GLUT4 vesicle trafficking in rat adipocytes after ethanol feeding: regulation by heterotrimeric G-proteins.
2001 Mar 1
Structure of a sialic acid-activating synthetase, CMP-acylneuraminate synthetase in the presence and absence of CDP.
2001 Mar 16
Characterization of the stromal cell-derived factor-1alpha-heparin complex.
2001 Mar 16
Patents

Sample Use Guides

In Vivo Use Guide
no more than 80 to 3000 mg saccharin per kilogram or litre should be used
Route of Administration: Oral
In Vitro Use Guide
After assaying for prolactin (PRL) in saccharin-treated cultures, it was observed that this sweetener is also capable of stimulating PRL production two- to sixfold in a dose-dependent manner. Enhancement of PRL production can be observed at 0.5 mM saccharin, yet this is 10 times less than the saccharin concentration required to alter cell shape. These effects of saccharin on cell morphology and on PRL production are reversible in rat pituitary tumor cells (GH4C1). When added to cultures along with maximal concentrations of epidermal growth factor (EGF) or thyrotropin-releasing hormone (TRH), the effects of saccharin on PRL production are additive, suggesting that the actions of saccharin are mediated by a somewhat different pathway from that of the peptide hormones
Substance Class Chemical
Created
by admin
on Fri Jun 25 23:55:03 UTC 2021
Edited
by admin
on Fri Jun 25 23:55:03 UTC 2021
Record UNII
63Q3BCF15A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMMONIUM SACCHARIN
FCC  
Common Name English
SACCHARINATE AMMONIUM
Common Name English
1,2-BENZISOTHIAZOLIN-3-ONE 1,1-DIOXIDE AMMONIUM SALT
Common Name English
1,2-BENZISOTHIAZOL-3(2H)-ONE, 1,1-DIOXIDE, AMMONIUM SALT
Common Name English
SACCHARIN AMMONIUM SALT [MI]
Common Name English
1,2-BENZISOTHIAZOL-3(2H)-ONE, 1,1-DIOXIDE, AMMONIUM SALT (1:1)
Common Name English
SUCLINE
Brand Name English
DARAMIN
Brand Name English
AMMONIUM SACCHARIN [FCC]
Common Name English
SACCHARIN AMMONIUM
Common Name English
Code System Code Type Description
EPA CompTox
6381-61-9
Created by admin on Fri Jun 25 23:55:03 UTC 2021 , Edited by admin on Fri Jun 25 23:55:03 UTC 2021
PRIMARY
ECHA (EC/EINECS)
228-971-8
Created by admin on Fri Jun 25 23:55:03 UTC 2021 , Edited by admin on Fri Jun 25 23:55:03 UTC 2021
PRIMARY
FDA UNII
63Q3BCF15A
Created by admin on Fri Jun 25 23:55:03 UTC 2021 , Edited by admin on Fri Jun 25 23:55:03 UTC 2021
PRIMARY
PUBCHEM
22877
Created by admin on Fri Jun 25 23:55:03 UTC 2021 , Edited by admin on Fri Jun 25 23:55:03 UTC 2021
PRIMARY
CAS
6381-61-9
Created by admin on Fri Jun 25 23:55:03 UTC 2021 , Edited by admin on Fri Jun 25 23:55:03 UTC 2021
PRIMARY
MERCK INDEX
M9715
Created by admin on Fri Jun 25 23:55:03 UTC 2021 , Edited by admin on Fri Jun 25 23:55:03 UTC 2021
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE